8 news items
Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial Monoclonal Antibodies
IVVD
31 May 24
conditions or receipt of certain immunosuppressive medications or treatments and are unlikely to mount an adequate immune response to COVID-19 vaccination
Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
IVVD
31 May 24
medications or treatments and are unlikely to mount an adequate immune response to COVID-19 vaccination. Recipients should not be currently infected
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
IVVD
7 May 24
to mount an adequate immune response to COVID-19 vaccination. Recipients should not be currently infected with or have had a known recent exposure
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDAâ„¢
IVVD
15 Apr 24
and are unlikely to mount an adequate immune response to COVID-19 vaccination. Recipients should not be currently infected with or have had a known recent
Invivyd Announces CEO Transition
IVVD
12 Apr 24
-to-day leadership of the company with Jeremy, who is primarily responsible for our commercial execution, and I personally look forward to partnering
4kkg5hp140a11gow6rkxdz4k
IVVD
4 Apr 24
medical conditions or receipt of certain immunosuppressive medications or treatments and are unlikely to mount an adequate immune response to COVID-19
fdyvl9jjrb0ew8c46 ouonneta16vcejwimy5s44b5a689h7
IVVD
22 Mar 24
and are unlikely to mount an adequate immune response to COVID-19 vaccination. Recipients should not be currently infected with or have had a known recent
5aycs
IVVD
22 Mar 24
an adequate immune response to COVID-19 vaccination. Recipients should not be currently infected with or have had a known recent exposure
- Prev
- 1
- Next